Notably, high transcriptional levels of PLOD1 (P = 0.0073), PLOD2 (P = 0.00043), and PLOD3 (P = 0.012) were markedly associated with shorter OS in HCC patients. This evidence concerns the gene PLOD2 and hepatocellular carcinoma.